The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
16.61
-0.50 (-2.92%)
Jul 31, 2026, 4:00 PM EDT - Market closed
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,821 | 5,808 | 5,782 | 6,078 | 6,831 | 6,345 | |
Revenue Growth | 0.55% | 0.45% | -4.87% | -11.02% | 7.66% | 27.69% |
Cost of Revenue | 4,942 | 4,906 | 4,640 | 4,776 | 5,215 | 4,964 |
Gross Profit | 879 | 902 | 1,142 | 1,302 | 1,616 | 1,381 |
Selling, General & Admin | 823 | 799 | 598 | 1,286 | 710 | 592 |
Research & Development | 107 | 108 | 109 | 108 | 118 | 107 |
Other Operating Expenses | 39 | 59 | 116 | 153 | 16 | 6 |
Total Operating Expenses | 969 | 966 | 823 | 1,547 | 844 | 705 |
Operating Income | -90 | -64 | 319 | -245 | 772 | 676 |
Interest Income | 34 | 35 | 43 | 45 | 55 | 43 |
Interest Expense | -272 | -269 | -263 | -208 | -163 | -185 |
Other Non-Operating Income (Expense) | 43 | 21 | 7 | 90 | 77 | 142 |
Total Non-Operating Income (Expense) | -195 | -213 | -213 | -73 | -31 | 0 |
Pretax Income | -285 | -277 | 106 | -318 | 741 | 676 |
Provision for Income Taxes | 112 | 109 | 37 | -66 | 163 | 68 |
Net Income | -411 | -386 | 69 | -252 | 578 | 608 |
Minority Interest in Earnings | - | - | - | 1 | - | - |
Net Income to Common | -411 | -386 | 69 | -253 | 578 | 608 |
Net Income Growth | - | - | - | - | -4.93% | 177.63% |
Shares Outstanding (Basic) | 150 | 150 | 149 | 149 | 155 | 165 |
Shares Outstanding (Diluted) | 151 | 150 | 150 | 149 | 158 | 169 |
Shares Change | 0.43% | 0.04% | 0.85% | -5.93% | -6.27% | 1.53% |
EPS (Basic) | -2.64 | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 |
EPS (Diluted) | -2.64 | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 |
EPS Growth | - | - | - | - | 1.39% | 172.73% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 154 | 51 | -993 | 186 | 448 | 537 |
Free Cash Flow Growth | - | - | - | -58.48% | -16.57% | -0.56% |
Free Cash Flow Per Share | 1.02 | 0.34 | -6.61 | 1.25 | 2.83 | 3.18 |
Dividends Per Share | 0.350 | 0.512 | 1.000 | 1.000 | 1.000 | 1.000 |
Dividend Growth | -65.00% | -48.75% | 0% | 0% | 0% | 0% |
Gross Margin | 15.10% | 15.53% | 19.75% | 21.42% | 23.66% | 21.77% |
Operating Margin | -1.55% | -1.10% | 5.52% | -4.03% | 11.30% | 10.65% |
Profit Margin | -7.06% | -6.65% | 1.19% | -4.15% | 8.46% | 9.58% |
FCF Margin | 2.65% | 0.88% | -17.17% | 3.06% | 6.56% | 8.46% |
EBITDA | 241 | 276 | 628 | 47 | 1,063 | 993 |
EBITDA Margin | 4.14% | 4.75% | 10.86% | 0.77% | 15.56% | 15.65% |
EBIT | -90 | -64 | 319 | -245 | 772 | 676 |
EBIT Margin | -1.55% | -1.10% | 5.52% | -4.03% | 11.30% | 10.65% |
Effective Tax Rate | -39.30% | -39.35% | 34.91% | 20.75% | 22.00% | 10.06% |